CDC is currently conducting research to determine if two masks are better than one
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Lab-made antibodies are showing promise for preventing Covid-19 infection in those at high risk of contracting the disease. With vaccines in short supply in the United States and elsewhere, the drugs could be used to provide short-term protection until people can get vaccinated.
Submitted by mike kraft on
Submitted by mike kraft on
Coronavirus variants popping up across the US are beginning to affect tests for the virus, the US Food and Drug Administration said Wednesday.
Submitted by mike kraft on
Submitted by mike kraft on
Merck said Monday it will stop developing both of the current formulations of the Covid-19 vaccines the company was working on, citing inadequate immune responses to the shots.
Submitted by mike kraft on
Submitted by mike kraft on
Israel’s coronavirus tsar has warned that a single dose of the Pfizer/BioNTech vaccine may be providing less protection than originally hoped, as the country reported a record 10,000 new Covid infections on Monday.
In remarks reported by Army Radio, Nachman Ash said a single dose appeared “less effective than we had thought”, and also lower than Pfizer had suggested.
By contrast, those who had received their second dose of the Pfizer vaccine had a six- to 12-fold increase in antibodies, according to data released by Sheba Medical Center in Tel Hashomer on Monday.
Submitted by mike kraft on
Submitted by mike kraft on